129 related articles for article (PubMed ID: 15356648)
1. PI3-K/AKT/FKHR and MAPK signaling cascades are redundantly stimulated by a variety of cytokines and contribute independently to proliferation and survival of multiple myeloma cells.
Lentzsch S; Chatterjee M; Gries M; Bommert K; Gollasch H; Dörken B; Bargou RC
Leukemia; 2004 Nov; 18(11):1883-90. PubMed ID: 15356648
[TBL] [Abstract][Full Text] [Related]
2. Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma.
Hideshima T; Nakamura N; Chauhan D; Anderson KC
Oncogene; 2001 Sep; 20(42):5991-6000. PubMed ID: 11593406
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells.
Jackson JG; Kreisberg JI; Koterba AP; Yee D; Brattain MG
Oncogene; 2000 Sep; 19(40):4574-81. PubMed ID: 11030146
[TBL] [Abstract][Full Text] [Related]
5. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
Dijkers PF; Birkenkamp KU; Lam EW; Thomas NS; Lammers JW; Koenderman L; Coffer PJ
J Cell Biol; 2002 Feb; 156(3):531-42. PubMed ID: 11815629
[TBL] [Abstract][Full Text] [Related]
6. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
Tu Y; Gardner A; Lichtenstein A
Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
[TBL] [Abstract][Full Text] [Related]
7. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
Mitsiades CS; Mitsiades N; Poulaki V; Schlossman R; Akiyama M; Chauhan D; Hideshima T; Treon SP; Munshi NC; Richardson PG; Anderson KC
Oncogene; 2002 Aug; 21(37):5673-83. PubMed ID: 12173037
[TBL] [Abstract][Full Text] [Related]
8. Follicle-stimulating hormone promotes nuclear exclusion of the forkhead transcription factor FoxO1a via phosphatidylinositol 3-kinase in porcine granulosa cells.
Cunningham MA; Zhu Q; Unterman TG; Hammond JM
Endocrinology; 2003 Dec; 144(12):5585-94. PubMed ID: 12960025
[TBL] [Abstract][Full Text] [Related]
9. Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells.
Lentzsch S; Gries M; Janz M; Bargou R; Dörken B; Mapara MY
Blood; 2003 May; 101(9):3568-73. PubMed ID: 12506012
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
Brunet A; Park J; Tran H; Hu LS; Hemmings BA; Greenberg ME
Mol Cell Biol; 2001 Feb; 21(3):952-65. PubMed ID: 11154281
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
[TBL] [Abstract][Full Text] [Related]
12. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells.
Mazumdar A; Kumar R
FEBS Lett; 2003 Jan; 535(1-3):6-10. PubMed ID: 12560069
[TBL] [Abstract][Full Text] [Related]
13. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma.
Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D
Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656
[TBL] [Abstract][Full Text] [Related]
14. Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway.
G-Amlak M; Uddin S; Mahmud D; Damacela I; Lavelle D; Ahmed M; van Besien K; Wickrema A
Biochem Biophys Res Commun; 2002 Oct; 297(4):760-4. PubMed ID: 12359217
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the PI 3-kinase signaling pathway in progression of colon adenocarcinoma.
Khaleghpour K; Li Y; Banville D; Yu Z; Shen SH
Carcinogenesis; 2004 Feb; 25(2):241-8. PubMed ID: 14578160
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells.
Abid MR; Guo S; Minami T; Spokes KC; Ueki K; Skurk C; Walsh K; Aird WC
Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):294-300. PubMed ID: 14656735
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
Lee BC; Lee TH; Avraham S; Avraham HK
Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
[TBL] [Abstract][Full Text] [Related]
18. Role of the AKT kinase in expansion of multiple myeloma clones: effects on cytokine-dependent proliferative and survival responses.
Hsu JH; Shi Y; Hu L; Fisher M; Franke TF; Lichtenstein A
Oncogene; 2002 Feb; 21(9):1391-400. PubMed ID: 11857082
[TBL] [Abstract][Full Text] [Related]
19. Blocking of c-FLIP(L)--independent cycloheximide-induced apoptosis or Fas-mediated apoptosis by the CC chemokine receptor 9/TECK interaction.
Youn BS; Kim YJ; Mantel C; Yu KY; Broxmeyer HE
Blood; 2001 Aug; 98(4):925-33. PubMed ID: 11493434
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 activates phosphoinositol-3' kinase in multiple myeloma tumor cells by signaling through RAS-dependent and, separately, through p85-dependent pathways.
Hsu JH; Shi Y; Frost P; Yan H; Hoang B; Sharma S; Gera J; Lichtenstein A
Oncogene; 2004 Apr; 23(19):3368-75. PubMed ID: 15021914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]